“July is a critical month for several leading biotech companies, and there’s a lot that investors need to know if they want to make a prudent decision about whether to invest,” advises the author of today’s article. He proceeds to examine three particular biotech stocks to watch this month and what investors need to know about each of them. For these three biotech stocks – including a gene therapy company whose “first major pipeline project is just months away from potentially getting regulatory approval” – CLICK HERE.